Skip to content
healthcare.dev

Levetiracetam

NDC 63323-400, LEVETIRACETAM, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-400
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090876
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM100 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
63323-400-056332304000510 VIAL, SINGLE-USE in 1 TRAY (63323-400-05) / 5 mL in 1 VIAL, SINGLE-USE (63323-400-01)
63323-400-446332304004410 VIAL, SINGLE-USE in 1 TRAY (63323-400-44) / 5 mL in 1 VIAL, SINGLE-USE (63323-400-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=63323-400
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-400

Use it

Look up 63323-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.